Genco Shipping & Trading Limited Board of Directors Provides Update on Review of Diana Shipping’s Revised, Non-Binding Indicative Proposal

Genco (NYSE: GNK) is reviewing Diana Shipping’s revised, non-binding proposal to acquire all outstanding shares not already owned by Diana for $24.80 per share in cash plus one Diana share, and says its advisors have evaluated whether the offer fairly reflects GNK NAV and an appropriate control premium. Genco highlights concerns around Diana valuing the stock component at $2.54 versus Diana’s $2.30 close on June 16 and $2.20 close on July 22, potential dilution from new share issuance, and Diana’s plan to sell 16 GNK vessels to Star Bulk at below-market prices. Genco reiterates a strong recommendation not to tender into the separate $24.80 per share cash-only offer, noting it does not include the Diana share component.

Analysis

GNK is the cleaner residual claim here: the board’s public push raises the odds of either a higher price or a broken-process premium, while the company’s own cash generation keeps resetting the floor every quarter. The market is likely underpricing how much leverage GNK has simply by waiting in a rising drybulk tape; each month of strong rates makes the control premium more expensive for the buyer and more defensible for GNK.

DSX is the more fragile leg because its bid currency is simultaneously the source of its own risk. Any incremental dilution, asset-sale execution, or stock drawdown mechanically weakens the consideration, so the deal has a reflexive negative feedback loop that can widen the spread even if headline terms look unchanged. That makes DSX less a classic acquirer and more a financing vehicle with NAV leakage risk.

Catalysts are near-term: the tender deadline, the Q2 dividend announcement, and any revised offer language in the next 1-3 weeks. Over 1-3 months, the key question is whether drybulk fundamentals stay firm enough to force a better mix or whether the board can use cash returns to keep shareholders patient. The main falsifier is a meaningful drop in spot freight rates or an unchanged/low revised bid that proves the board is just managing optics rather than extracting value.

Contrarian view: the consensus may be too focused on the headline premium and not enough on the buyer’s self-dilution. If DSX stock weakens further, the implied bid can effectively shrink without any formal cut, which argues for trading the spread rather than the absolute names. But if the deal collapses, GNK likely still trades on asset value plus dividend capacity, so the downside is more limited than a generic merger-arb widowmaker.

Key Decisions for Investors

• Long GNK / short DSX as a 1-4 week event-driven pair; thesis is GNK has superior negotiating leverage and dividend-supported downside, while DSX carries dilution-driven bid fragility. Falsifier: DSX outperforms GNK by >10% on a revised all-cash or cash-heavy proposal.
• If already long GNK, hold through the next dividend and board update rather than selling into the first pop; the better risk/reward is on a revised term sheet, not the initial headline. Trim only if the implied takeout value stops rising while drybulk rates roll over.
• Avoid initiating a standalone DSX long into the review period; any upside is capped by financing/dilution concerns and is more suitable as a tactical short-cover than a structural long. Reassess only if DSX announces a materially higher-cash structure with no incremental share issuance.
• Watch GNK on a 1-3 month basis as a value-plus-catalyst name; if no better bid emerges, the stock still has support from ongoing capital returns, but if the Q2 dividend disappoints, the standalone floor falls quickly. Falsifier: a weaker-than-expected dividend or guidance reset.
• No direct trade in MS; treat it as non-causal headline color unless a formal advisory fee or financing role appears in filings.